| Oxford nanopore next generation sequencing in a front-line clinical microbiology laboratory without on-site bioinformaticians M Bloomfield, S Hutton, C Velasco, M Burton, M Benton, M Storey Pathology 56 (3), 444-447, 2024 | | 2024 |
| Impact of the COVID‐19 related border restrictions on influenza and other common respiratory viral infections in New Zealand QS Huang, N Turner, T Wood, A Anglemyer, P McIntyre, N Aminisani, ... Influenza and Other Respiratory Viruses 18 (2), e13247, 2024 | 1 | 2024 |
| Building expertise on FAIR through evolving Bring Your Own Data (BYOD) workshops: describing the data, software, and management-focused approaches and their evolution CH Bernabé, L Thielemans, R Kaliyaperumal, C Carta, S Zhang, ... Data Intelligence, 1-23, 2023 | 3 | 2023 |
| Pangenome graphs in infectious disease: a comprehensive genetic variation analysis of Neisseria meningitidis leveraging Oxford Nanopore long reads Z Yang, A Guarracino, PJ Biggs, MA Black, N Ismail, JR Wold, ... Frontiers in Genetics 14, 1225248, 2023 | | 2023 |
| Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: insights from Aotearoa New Zealand M Bunce, JL Geoghegan, D Winter, J de Ligt, S Wiles BMC medicine 21 (1), 213, 2023 | 1 | 2023 |
| Building pangenome graphs E Garrison, A Guarracino, S Heumos, F Villani, Z Bao, L Tattini, ... bioRxiv, 2023.04. 05.535718, 2023 | 34 | 2023 |
| Global diversity and antimicrobial resistance of typhoid fever pathogens: insights from 13,000 Salmonella Typhi genomes ME Carey, ZA Dyson, DJ Ingle, A Amir, MK Aworh, MA Chattaway, ... medRxiv, 2022.12. 28.22283969, 2022 | 14* | 2022 |
| Temporal associations of the COVID-19 related border restrictions and respiratory viral infections in New Zealand QS Huang, N Turner, T Wood, J Geoghegan, A Anglemyer, P McIntyre, ... | | 2022 |
| Global disparities in SARS-CoV-2 genomic surveillance AF Brito, E Semenova, G Dudas, GW Hassler, CC Kalinich, MUG Kraemer, ... Nature communications 13 (1), 7003, 2022 | 188 | 2022 |
| Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border J Douglas, D Winter, A McNeill, S Carr, M Bunce, N French, J Hadfield, ... Nature Communications 13 (1), 6484, 2022 | 16 | 2022 |
| Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand L Jelley, J Douglas, X Ren, D Winter, A McNeill, S Huang, N French, ... Nature Communications 13 (1), 4035, 2022 | 20 | 2022 |
| Airborne transmission of SARS-CoV-2 delta variant within tightly monitored isolation facility, New Zealand (Aotearoa) A Fox-Lewis, F Williamson, J Harrower, X Ren, GJB Sonder, A McNeill, ... Emerging infectious diseases 28 (3), 501, 2022 | 29 | 2022 |
| Phylodynamics reveals the role of human travel and contact tracing in controlling the first wave of COVID-19 in four island nations J Douglas, FK Mendes, R Bouckaert, D Xie, CL Jiménez-Silva, ... Virus evolution 7 (2), veab052, 2021 | 37 | 2021 |
| COVID-19 vaccine strategies for Aotearoa New Zealand: a mathematical modelling study T Nguyen, M Adnan, BP Nguyen, J de Ligt, JL Geoghegan, R Dean, ... The Lancet Regional Health–Western Pacific 15, 2021 | 23 | 2021 |
| Real-time genomics for tracking severe acute respiratory syndrome coronavirus 2 border incursions after virus elimination, New Zealand J Douglas, JL Geoghegan, J Hadfield, R Bouckaert, M Storey, X Ren, ... Emerging infectious diseases 27 (9), 2361, 2021 | 38 | 2021 |
| Identification of novel human Wnt target genes using adult endodermal tissue-derived organoids KE Boonekamp, I Heo, B Artegiani, P Asra, G van Son, J de Ligt, ... Developmental Biology 474, 37-47, 2021 | 23 | 2021 |
| Use of genomics to track coronavirus disease outbreaks, New Zealand JL Geoghegan, J Douglas, X Ren, M Storey, J Hadfield, OK Silander, ... Emerging Infectious Diseases 27 (5), 1317, 2021 | 40 | 2021 |
| Transmission of severe acute respiratory syndrome coronavirus 2 during border quarantine and air travel, New Zealand (Aotearoa) N Eichler, C Thornley, T Swadi, T Devine, C McElnay, J Sherwood, ... Emerging infectious diseases 27 (5), 1274, 2021 | 91 | 2021 |
| Genomic evidence of in-flight transmission of SARS-CoV-2 despite predeparture testing T Swadi, JL Geoghegan, T Devine, C McElnay, J Sherwood, P Shoemack, ... Emerging infectious diseases 27 (3), 687, 2021 | 81* | 2021 |
| Lack of N2-gene amplification on the Cepheid Xpert Xpress SARS-CoV-2 assay and potential novel causative mutations: A case series from Auckland, New Zealand S Fox-Lewis, A Fox-Lewis, J Harrower, R Chen, J Wang, J de Ligt, ... IDCases 25, e01233, 2021 | 12 | 2021 |
Lisenka VissersProfessor of Translational Genomics 🧬Verified email at radboudumc.nl
